Biotech & MedTech



Latest Comments
image_pdfimage_print

Brent Willis of Voyageur Pharmaceuticals on securing a domestic medical imaging agent supply

In this InvestorIntel interview with host Tracy Weslosky, Voyageur Pharmaceuticals Ltd.‘s (TSXV: VM) President and CEO Brent Willis, discusses supply […]


Valeo Pharma revenues jump on increased market share from growing drug portfolio

Valeo Pharma Inc. (TSX: VPH | OTCQB: VPHIF) is a Canadian pharmaceutical company that is seeing significant success with its […]


David Regan of Sona Nanotech talks about developments in its unique gold nanorod technology

In this InvestorIntel interview with host Tracy Weslosky, Sona Nanotech Inc.‘s (CSE: SONA | OTCQB: SNANF) CEO David Regan talks […]


Addiction may have met its match in Awakn Life Sciences therapeutics

Addiction is one of the biggest unmet medical needs globally with substance and behavioral addictions affecting a significant proportion of […]


Greg Fenton of Zentek discusses recent news including a NASDAQ listing and a distribution agreement

In this InvestorIntel interview with host Tracy Weslosky, Zentek Ltd. (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg Fenton […]


Voyageur Pharmaceuticals completes FDA submission milestone for first barium contrast product license application

Radiographic contrast media are substances used in diagnostic imaging tests such as ultrasound, X-rays, CT scans and MRI to enhance […]


With technology for the real world, Zentek’s graphene nanotech masks are now on store shelves

At the start of the year, I was asked to pick a name that I thought could be the “stock […]


Thomas Smeenk of Hemostemix talks about market reaction to successful litigation settlement

In this InvestorIntel interview with host Stephen Lautens, Hemostemix Inc.’s (TSXV: HEM | OTCQB: HMTXF) Co-Founder, President and CEO Thomas […]


Nanotechnology value hunters look at Sixth Wave Innovations

After the last few days and weeks, it seems almost pointless talking about any company that is publicly traded as […]


Anthony Tennyson of Awakn Life Sciences talks about their portfolio of revolutionary therapeutics and clinics to treat addiction

In this InvestorIntel interview with host Tracy Weslosky, Awakn Life Sciences Corp.’s (NEO: AWKN | OTCQB: AWKNF) Co-Founder & CEO Anthony […]